| |
C. 5. Medicaments |
|
| |
Methodology |
|
| |
On the permanent address of the beneficiary of the prescription |
|
| |
5.1. Summary data of the subsidized turnover of pharmacies, 2010
|
|
| |
5.2. Main data of the subsidized turnover of pharmacies by legal title, 2010
|
|
| |
5.2.1. Development of the subsidized turnover of pharmacies within the subsidisation category linked to enhanced indication by sex and age group, 2010
|
|
| |
5.2.2. Development of the subsidized turnover of pharmacies within the subsidisation category linked to lifted indication by sex and age group, 2010
|
|
| |
5.2.3. Main data of the subsidized turnover within the normative subsidisation category, 2010
|
|
| |
5.2.3.1. Development of the turnover subsidized up to 90%, 2010
|
|
| |
5.2.3.2. Development of the turnover subsidized up to 85% by sex and age group, 2010
|
|
| |
5.2.3.3. Development of the turnover subsidized up to 55% by sex and age group, 2010
|
|
| |
5.2.3.4. Development of the turnover subsidized up to 50% by sex and age group, 2010
|
|
| |
5.2.3.5. Development of the turnover subsidized up to 25% by sex and age group, 2010
|
|
| |
5.2.3.6. Development of the turnover subsidized by fix amount by sex and age group, 2010
|
|
| |
5.2.3.7. Development of the normative public health care by sex and age group, 2010
|
|
| |
5.2.4. Development of the subsidized turnover of medicinal products within the subsidisation category linked to the equity legal title by sex and age group, 2010
|
|
| |
5.3. Summary data of public health care (enhanced+lifted+normative) from subsidised turnover, 2010
|
|
| |
On the basis of headquarters of the pharmacy redeeming the prescription |
|
| |
5.1. Summary data of the subsidized turnover of pharmacies, 2010
|
|
| |
5.2. Main data of the subsidized turnover of pharmacies by legal title, 2010
|
|
| |
5.2.1. Development of the subsidized turnover of pharmacies within the subsidisation category linked to enhanced indication by sex and age group, 2010
|
|
| |
5.2.2. Development of the subsidized turnover of pharmacies within the subsidisation category linked to lifted indication by sex and age group, 2010
|
|
| |
5.2.3. Main data of the subsidized turnover within the normative subsidisation category, 2010
|
|
| |
5.2.3.1. Development of the turnover subsidized up to 85% by sex and age group, 2010
|
|
| |
5.2.3.2. Development of the turnover subsidized up to 55% by sex and age group, 2010
|
|
| |
5.2.3.3. Development of the turnover subsidized up to 50% by sex and age group, 2010
|
|
| |
5.2.3.4. Development of the turnover subsidized up to 25% by sex and age group, 2010
|
|
| |
5.2.3.5. Development of the turnover subsidized by fix amount by sex and age group, 2010
|
|
| |
5.2.3.6. Development of the normative public health care by sex and age group, 2010
|
|
| |
5.2.4. Development of the subsidized turnover of medicinal products within the subsidisation category linked to the equity legal title by sex and age group, 2010
|
|
| |
5.3. Summary data of public health care (enhanced+lifted+normative) from subsidised turnover, 2010
|
|
NHIFA Department of Statistics and Operational Analysis Statistical Division, Oktober 2011